Posted January 28, 2012de Awakenings | 69 comments
We continue to disseminate any information about the dangers of vaccines that can help people not to fall into the trap of those gangsters industry sectors of health that could cost you dearly in their children for life. Please make a careful search, investigate, inquire and act accordingly, knowledge is your ally. IGNORANCE, KILLS ! !
Awakenings
A scientific report of the Medical Association of Peru hazard complaint with evidence of this vaccine, indicating that both Gardasil and Cervarix to are based on false propaganda and have not demonstrated effectiveness in the treatment of HPV. The report was written by and for specialists: Doctors and health professionals. This article is a call to consciousness and take responsibility of physicians for prescribing vaccines, thinking about the health and welfare of girls and boys.
VACCINES PAPILLOMAVIRUS HUMAN: BETWEEN THE MISINFORMATION AND CONFLICT OF INTEREST
A vaccine against cervical cancer, can be considered all scientific and historical landmark. "Cervical cancer is the second most common malignancy in women worldwide, which generally affects younger individuals than other cancers." 1
These statements are repeated in the literature on the efficacy of vaccines against Human Papilloma Virus (HPV), usually performed by researchers with serious conflicts of interest related to the manufacturing laboratories.
This type of advertising, generated a global enthusiasm for these new vaccines. The health authorities in many developed countries, including developing countries, such as Peru and Panama, incorporated them into their national immunization programs, with burdensome expenses, but without scientific support.
Peru, invested 76 million soles in the purchase of these vaccines, which contrasts with only 3 million per year, which are assigned to the entire National Program for Cervical Cancer screening uterino.2 This explains the poor coverage of 30%, and consequently the diagnosis is late or never and that is why, the female population is condemned to the consequences of delayed diagnosis and death from cancer.
The vaccines currently on the market, Gardasil (licensed since 2007) 3 and Cervarix (2009) 4, whose main objective, prevent HPV infection, which the laboratory is the main protagonist of this painful disease. However, it is important to mention that Harald Zur Hausen German, received the Nobel Prize in 2008 for HPV related to cervical cancer, but to date the virus has not been isolated from the lesions. There is also the controversy of patients with cervical cancer, but HPV infection.
The two vaccines containing virus-like particles (VLPs), which are particles in the viral envelope. L1 coat protein and variation in a few amino acids determines the serotype specificity. Thus Gardasiles tetravalent vaccine containing serotypes 4 L1 proteins (16/18/11/6) and Cervarix is bivalent (16/18), but without the presence of DNA viral.3, 4
Incidentally, the serious adverse reactions, the Peruvian Medical Association (PMA), thoroughly reviewed clinical trials of both vaccines, and reports of countries with a good Drug Surveillance System.
We CONSIDERED IMPORTANT INFORMATION RELEVANT TO SHARE WITH YOU, as described below:
1 Both vaccines have been studied in clinical trials within 5 years.5 When studies of new drugs or vaccines generally take 10 to 15 years. Even experts mention that demonstrate protection against cancer can take decades. 6
2nd There are more than 150 HPV types, about 40 infect humans and 20 are oncogenic. Therefore, vaccines that have only two oncogenic serotypes (16/18), can not be considered "protective of cervical cancer," and less with intermediate efficacy studies (Cervical Intraepithelial Neoplasia - NICs).
3rd In sexual debut, 90% of young people can be infected with HPV. However, the 90% effective acquire natural immunity, after 2 years with minimal presence or absence of anticuerpos.7, 8, 9 In this regard, increased antibodies in vaccines, can not demonstrate efficacy and fewer long term.
Both vaccines 4th possess aluminum salts as adjuvants recognized toxicity, to raise antibodies. Gardasil contains 225 ug / dose and Cervarix 500ug/dosis. Over 1,000 and 2,000 times respectively the Maximum Permissible limit recommended by WHO (0.2ug/ml). Furthermore, antibodies Cervarix increases more by the presence of monophosphoryl lipid A, endotoxin extracted dela powerful bacteria G (-), Salmonella minesota.
5th double-blind studies of Gardasil, amazingly were used as placebos: Aluminum salts, with doses of 225ug, 450ug. Including Hepatitis B vaccines, in order to minimize adverse reactions esperadas.10
6 As if this were not enough, this year, SANE VAX INC laboratory, DNA virus found in a teenager with serious adverse and in 13 samples of Gardasil reactions investigó.11 Wisely, sent a warning to the EMA and FDA, the presence of DNA of this dangerous oncogenic virus. Unfortunately, within 3 weeks without any investigation, both agencies acknowledged the presence of DNA, but said "we were only DNA fragments as part of the manufacturing process, and without any risk to vaccine recipients." Answer inconceivable, because all products derived through biotechnology, must go through a rigorous purification process as part of its control quality.12, 13
In the future, we should all be cautious in incorporating new vaccines into national immunization programs. Clinical trials of new vaccines must meet all pre-clinical and clinical studies and regulatory research time to ensure efficacy and safety.
Finally, Peru needs a Vaccine Act and create a compensation fund for Adverse Reactions. Only in this way, better vaccines for our children and adolescents acquire. The life and health must take precedence over commercial interests. I sincerely hope that regulatory agencies resume their mission, now so seriously questioned.
Bibliography
1.Harper, D.M. et al.Sustained efficacy up to 4.5 years of a bivalent L1 VRUS-like particle vaccine against human papillomavirus types 16 and 18: follow up from a randomized control trial. Lancet 367: 1247-1255, 2006.
2.Comunicación staff of officials from the Ministry of Health of Peru. Peruvian Society of Obstetrics and Gynecology. Forum about HPV vaccines. September 10, 2011.
Gardasil 3.Ficha technique. MSD-Sanofi Paster.
Cervarix 4.Ficha technique. GlaxoSmithKline Biologicals.
Spanish 5.Asociación of Pediatrics. Vaccine Advisory Committee. February 13, 2007. www.vacunasaep.org / advertencias.htm
6.Hang Ch.J. Human Papillomavirus Vaccination-Reasons for Caution. N.Engl.J.Med. 359: 861-62, 2008
7.Schwartz T. F., Leo, O. Immune response to human papillomavirus after prophylactic vaccination with adjuvanted HPV-16/18 vaccine-ASO4: Improving upon nature. Gynecil. Oncol, 110 (Suppl 1): 501-10, 2008.
8.StanleyM. HPV: a master at Avoiding the host defenses. HPV Today. 11: 1-16, 2007.
9.Navarro-Alonso J. A. et al:. Questions in the introduction of HPV vaccine in systematic calendars. Med.Clin. (Barc) 129 (2) 55-60, 2007
10. E. A. Joura et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomized clinical trials. Lancet, 369: 1693-1702, 2007
11. AAVP. Association of Concerned Papilloma Virus and Virus Laboratory findings INC SANE VAX.
12. Merck MSD.Respuesta of the Peruvian Association of Consumers, ASPEC, the presence of viral DNA in the Gardasil vaccine.
13. EMA. European Medicines Agency. Sane Vax Inc response to the presence of viral DNA in Gardasil
Sources: detenganlavacuna and Peruvian Medical Association
Visit Farmafia and Vaccines category to view more information about
Your vote: 27 votes
Share this on:
Google
Facebook473
Tuenti
Twitter20
meneame
LinkedIn2
Print & PDF
E-mail
Diigo
Tumblr
Pinterest
More
I like:
RelacionadoANDREA, NEW GIRL IN A COMA AFTER BEING VACCINATED AGAINST PAPILOMA
In "Vaccines" ANDREA DIED A FEW DAYS AFTER THE VACCINE PAPILOMA
In "Vaccines" USA, MIT MAKE NEW STUDY OF RELATIONSHIP BETWEEN ALUMINIUM OF VACCINES AND AUTISM
In "Vaccines".
No hay comentarios:
Publicar un comentario